Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Conditions: Buerger Disease; Raynaud Syndrome Intervention: Drug: BOTOX INJECTION Sponsor: University Hospital, Toulouse Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials